Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-13-112185
Filing Date
2013-03-18
Accepted
2013-03-18 14:34:16
Documents
19
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d447885d10k.htm 10-K 1281003
2 EX-10.6 d447885dex106.htm EX-10.6 52502
3 EX-10.7 d447885dex107.htm EX-10.7 13709
4 EX-10.20 d447885dex1020.htm EX-10.20 57238
5 EX-23.1 d447885dex231.htm EX-23.1 3961
6 EX-31.1 d447885dex311.htm EX-31.1 7852
7 EX-31.2 d447885dex312.htm EX-31.2 7876
8 EX-32.1 d447885dex321.htm EX-32.1 6043
15 GRAPHIC g447885g37g37.jpg GRAPHIC 44043
16 GRAPHIC g447885g46b60.jpg GRAPHIC 41800
17 GRAPHIC g447885g54n11.jpg GRAPHIC 31748
18 GRAPHIC g447885logo.jpg GRAPHIC 17779
19 GRAPHIC g447885logo1.jpg GRAPHIC 11928
  Complete submission text file 0001193125-13-112185.txt   7663054

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT aegr-20121231.xml EX-101.INS 984436
10 XBRL TAXONOMY EXTENSION SCHEMA aegr-20121231.xsd EX-101.SCH 79137
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aegr-20121231_cal.xml EX-101.CAL 90489
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aegr-20121231_def.xml EX-101.DEF 377870
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE aegr-20121231_lab.xml EX-101.LAB 566862
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aegr-20121231_pre.xml EX-101.PRE 444728
Mailing Address 101 MAIN STREET SUITE 1850 CAMBRIDGE MA 02142
Business Address 101 MAIN STREET SUITE 1850 CAMBRIDGE MA 02142 (617) 500-7867
Aegerion Pharmaceuticals, Inc. (Filer) CIK: 0001338042 (see all company filings)

EIN.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34921 | Film No.: 13697208
SIC: 2834 Pharmaceutical Preparations